Overview
ERIE INDEMNITY CO
Latest 10-K: FY2025, filed Feb 23, 2026 · Open the 10-K (Inline XBRL) ↗
- Revenue
- $4.07B
- 7.2%YoYup from FY2024
- TotalRevenue
- Gross profit
- Not reported
- Operating income
- $0.72B
- 6.0%YoYup from FY2024
- OperatingIncome
- Net income
- $0.56B
- 6.8%YoYdown from FY2024
- NetIncome
- Free cash flow
- $0.57B
- 17.4%YoYup from FY2024
At a glance
Growth
- ERIE INDEMNITY CO reported revenue of $4.07B for fiscal 2025, up 7.2% from fiscal 2024.
- Revenue grew faster than the median S&P 500 member in 3 of the last 5 fiscal years.
Profitability
- Operating margin was 17.6% and net margin was 13.8%, against a median net margin of 12.8% across S&P 500 members for the same fiscal year.
Written from the filed figures on this page by fixed rules — no AI.
Data as of Oct 31, 2026 · Sources: SEC EDGAR 10-K
Financial statements
Annual figures from the 10-K, most recent fiscal year first.
Income Statement
5 annual periodsChip: YoY change.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | 4Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $4.07B7.2%up Benchmark median 6.4% | $3.80B16.1%up Benchmark median 4.5% | $3.27B15.1%up Benchmark median 4.8% | $2.84B7.8%up Benchmark median 10.3% | $2.63B3.8%up Benchmark median 13.8% | 11.5% Benchmark median 6.6% |
| Gross Profit Median of 315 / 498 | — | — | — | — | — | — Benchmark median 6.2% |
| Operating Income Median of 373 / 498 | $717.18M6.0%up Benchmark median 7.3% | $676.46M30.0%up Benchmark median 7.4% | $520.26M38.3%up Benchmark median 4.9% | $376.21M18.3%up Benchmark median 7.5% | $318.10M5.9%down Benchmark median 23.5% | 22.5% Benchmark median 7.2% |
| Net Income | $559.34M6.8%down Benchmark median 4.8% | $600.31M34.6%up Benchmark median 5.7% | $446.06M49.4%up Benchmark median 1.9% | $298.57M0.2%up Benchmark median 1.3% | $297.86M1.6%up Benchmark median 33.9% | 17.1% Benchmark median 4.1% |
| EPS (Diluted) | — | — | — | — | — | — Benchmark median 5.6% |
Balance Sheet
5 annual periodsChip: YoY change.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | 4Y CAGR |
|---|---|---|---|---|---|---|
| Total Assets | $3.36B16.2%up Benchmark median 5.6% | $2.89B16.9%up Benchmark median 3.4% | $2.47B10.4%up Benchmark median 4.1% | $2.24B0.1%down Benchmark median 2.2% | $2.24B5.9%up Benchmark median 6.7% | 10.6% Benchmark median 4.7% |
| Total Liabilities Median of 357 / 498 | $1.07B18.9%up Benchmark median 6.4% | $0.90B11.4%up Benchmark median 1.9% | $0.81B2.3%up Benchmark median 2.9% | $0.79B12.1%down Benchmark median 2.0% | $0.90B3.2%down Benchmark median 5.2% | 4.5% Benchmark median 4.4% |
| Stockholders' Equity | $2.28B14.9%up Benchmark median 6.8% | $1.99B19.5%up Benchmark median 5.4% | $1.66B14.8%up Benchmark median 7.3% | $1.45B7.9%up Benchmark median 2.5% | $1.34B13.0%up Benchmark median 9.0% | 14.2% Benchmark median 6.1% |
| Cash & Equivalents | — | — | — | — | — | — Benchmark median 2.0% |
| Total Debt | — | — | — | $0.00M100.0%down Benchmark median 0.1% | $93.83M2.1%down Benchmark median -0.1% | — Benchmark median 4.3% |
Cash Flow Statement
5 annual periodsChip: YoY change.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | 4Y CAGR |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $686.66M12.3%up Benchmark median 6.3% | $611.25M60.3%up Benchmark median 4.8% | $381.20M4.1%up Benchmark median 9.9% | $366.15M9.1%down Benchmark median -0.7% | $402.79M17.6%up Benchmark median 10.7% | 14.3% Benchmark median 7.0% |
| Capital Expenditures | $115.69M7.3%down Benchmark median 5.4% | $124.84M34.8%up Benchmark median 2.8% | $92.65M37.9%up Benchmark median 11.3% | $67.20M54.8%down Benchmark median 14.0% | $148.80M168.0%up Benchmark median 8.1% | -6.1% Benchmark median 9.0% |
| Free Cash Flow Median of 378 / 498 | $570.97M17.4%up Benchmark median 7.3% | $486.40M68.6%up Benchmark median 6.1% | $288.56M3.5%down Benchmark median 8.8% | $298.95M17.7%up Benchmark median -11.3% | $253.99M11.5%down Benchmark median 10.2% | 22.4% Benchmark median 4.9% |
n/m: not meaningful — the base (the prior year, or the first year for the CAGR) was zero or negative, or a per-share figure’s share basis changed (stock split). “—” means the figure is not available.
Benchmark median = median of the companies in the benchmark universe on Dec 31 of each fiscal year, from their own 10-K filings; a change counts only companies whose prior year was positive. Each median uses every member that reports the line item; where fewer than 80% do (banks and insurers file no gross profit), the row names how many. Published where at least 250 companies report it. Updated 2026-10-27. This compares reported figures, not share-price returns. Methodology
Ratios & valuation
FY2025Every ratio read two ways: Wall Street’s popular formula and the value investor’s stricter one. Same question, same unit. Pick a ratio.
Quality · Return on capital
Profit earned on the money in the business
26.2%
Wall Street
ROE: net income ÷ equity
FY2024 32.9%
23.8%
Value investor
ROIC: after-tax operating profit ÷ invested capital
FY2024 26.2%
Gap −2.4 pts: Value-investor figure 2.4 points lower
How it’s calculated
Wall Street · ROE: net income ÷ equity
Net income ÷ average stockholders' equity (start and end of year), including noncontrolling interests. Buybacks shrink equity and lift it.
return_on_equity (ratio table)
Value investor · ROIC: after-tax operating profit ÷ invested capital
Operating profit after tax ÷ invested capital (total assets − cash − non-interest-bearing current liabilities), so leverage cannot flatter it
roic (ratio table)
Quality · Cash margin
Cash profit kept from each dollar of sales
19.3%
Wall Street
EBITDA margin
FY2024 19.3%
14.0%
Value investor
Free-cash-flow margin
FY2024 12.8%
Gap −5.3 pts: Value-investor figure 5.3 points lower
How it’s calculated
Wall Street · EBITDA margin
EBITDA ÷ revenue
ebitda ÷ revenue
Value investor · Free-cash-flow margin
(Operating cash flow − capital expenditures) ÷ revenue: taxes, interest, working capital and capex all paid
free cash flow ÷ revenue
Balance sheet · Liquidity
Short-term assets per dollar of bills due within a year
1.27×
Wall Street
Current ratio
FY2024 1.43×
1.27×
Value investor
Quick ratio, inventory excluded
FY2024 1.43×
Gap Same: Both views read the same
How it’s calculated
Wall Street · Current ratio
Current assets ÷ current liabilities
current_ratio (ratio table)
Value investor · Quick ratio, inventory excluded
(Current assets − inventory) ÷ current liabilities
quick_ratio (ratio table)
Each ratio measures one thing two ways, in the same unit: the popular formula, then a stricter one, so a lower figure is the stricter reading. Gap = value-investor figure minus Wall Street figure, from the figures shown.
Price-based ratios use the fiscal-year-end closing price. Free cash flow = operating cash flow − capital expenditures (we compute it; filings rarely report it). n/m = not meaningful (denominator ≤ 0); “—” = not reported. Each ratio’s formulas are under “How it’s calculated”.
Smart money
Showing the most recent 5 annual periods. Get longer history on the Pro plan, or the full history (1993–present) plus the smart-money dataset and webhooks on Institutional.
Peers, filings & research
Research Reports
No published research on ERIE yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on ERIE and publish the result to your public profile.
Cite this page
Data as of Oct 31, 2026. Canonical address: https://valuein.biz/data/ERIE
Valuein. (2026, October 31). ERIE INDEMNITY CO (ERIE) financial statements, earnings power and smart-money summary [Data set]. Source: SEC EDGAR filings. https://valuein.biz/data/ERIE
@misc{valuein_erie_2026,
author = {{Valuein}},
title = {ERIE INDEMNITY CO (ERIE) financial statements, earnings power and smart-money summary},
year = {2026},
howpublished = {\url{https://valuein.biz/data/ERIE}},
note = {Data as of 2026-10-31; source: SEC EDGAR filings}
}10-K filed Feb 23, 2026 · accession 0001628280-26-010666
Agents: every figure Valuein's tools return carries a fact_id that traces to its SEC filing.
point-in-time · survivorship-free · every number traceable to its SEC filing
Index names are trademarks of their owners; Valuein is not affiliated with or endorsed by any index provider.